Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 388 entries
Sorted by: Best Match Show Resources per page
Applying a transformative justice approach to encourage the participation of Black and Latina Girls in computing

STEM and girls

Dickinson J, Erete S, Nacu D.
GSID: FZxAYISf1KsJ
S Erete, K Thomas, D Nacu, J Dickinson… - ACM Transactions on …, 2021 - dl.acm.org

… girls, experience while engaging in computing education [61… of Black and Latina girls in STEM and computing activities in … Latina middle school girls to participate in STEM, we propose …

Cite
Erete, S., Thomas, K., Nacu, D., Dickinson, J., Thompson, N., & Pinkard, N. (2021). Applying a transformative justice approach to encourage the participation of Black and Latina Girls in computing. ACM Transactions on Computing Education (TOCE), 21(4), 1-24.
Erete, Sheena, et al. "Applying a transformative justice approach to encourage the participation of Black and Latina Girls in computing." ACM Transactions on Computing Education (TOCE) 21.4 (2021): 1-24.
Copy Download .nbib Format: MLA
Remixing Minecraft to broaden participation in computing

Broadening participation in STEM

Dickinson J, Smith L.
GSID: tLN3k610wNgJ
U Acholonu, D Amato, J Dickinson, L Smith… - … Participation in …, 2016 - computer.org

Minecraft is one of the most popular games among youth today, experiencing sales over 100 million worldwide and channels on YouTube generating over 47 billion views. Our interest in the game environment is due to its innate computational mechanics...

Cite
Acholonu, U., Amato, D., Dickinson, J., Smith, L., Engel, J., Walker, E., ... & Pinkard, N. (2016, August). Remixing Minecraft to broaden participation in computing. In 2016 Research on Equity and Sustained Participation in Engineering, Computing, and Technology (RESPECT) (pp. 1-1). IEEE Computer Society.
Acholonu, Ugochi, et al. "Remixing Minecraft to broaden participation in computing." 2016 Research on Equity and Sustained Participation in Engineering, Computing, and Technology (RESPECT). IEEE Computer Society, 2016.
Copy Download .nbib Format: MLA
Erratum to: Cost-effectiveness of clostridial collagenase ointment on wound closure in patients with diabetic foot ulcers: economic analysis of results from a multicenter, randomized, open-label trial.

Journal of foot and ankle research

Motley TA, Gilligan AM, Lange DL, Waycaster CR, Dickerson JE.
PMID: 27493688
J Foot Ankle Res. 2016 Aug 04;9:28. doi: 10.1186/s13047-016-0160-7. eCollection 2016.

[This corrects the article DOI: 10.1186/s13047-015-0065-x.].

Cite
Motley TA, Gilligan AM, Lange DL, et al. Erratum to: Cost-effectiveness of clostridial collagenase ointment on wound closure in patients with diabetic foot ulcers: economic analysis of results from a multicenter, randomized, open-label trial. J Foot Ankle Res. 2016;9:28doi: 10.1186/s13047-016-0160-7.
Motley, T. A., Gilligan, A. M., Lange, D. L., Waycaster, C. R., & Dickerson, J. E. (2016). Erratum to: Cost-effectiveness of clostridial collagenase ointment on wound closure in patients with diabetic foot ulcers: economic analysis of results from a multicenter, randomized, open-label trial. Journal of foot and ankle research, 928. https://doi.org/10.1186/s13047-016-0160-7
Motley, Travis A, et al. "Erratum to: Cost-effectiveness of clostridial collagenase ointment on wound closure in patients with diabetic foot ulcers: economic analysis of results from a multicenter, randomized, open-label trial." Journal of foot and ankle research vol. 9 (2016): 28. doi: https://doi.org/10.1186/s13047-016-0160-7
Motley TA, Gilligan AM, Lange DL, Waycaster CR, Dickerson JE. Erratum to: Cost-effectiveness of clostridial collagenase ointment on wound closure in patients with diabetic foot ulcers: economic analysis of results from a multicenter, randomized, open-label trial. J Foot Ankle Res. 2016 Aug 04;9:28. doi: 10.1186/s13047-016-0160-7. eCollection 2016. PMID: 27493688; PMCID: PMC4973526.
Copy Download .nbib Format: NLM
Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes.

Frontiers in immunology

Gam R, Shah P, Crossland RE, Norden J, Dickinson AM, Dressel R.
PMID: 28421078
Front Immunol. 2017 Apr 03;8:380. doi: 10.3389/fimmu.2017.00380. eCollection 2017.

The outcome of hematopoietic stem cell transplantation (HSCT) is controlled by genetic factors among which the leukocyte antigen human leukocyte antigen (HLA) matching is most important. In addition, minor histocompatibility antigens and non-HLA gene polymorphisms in genes controlling immune...

Cite
Gam R, Shah P, Crossland RE, et al. Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes. Front Immunol. 2017;8:380doi: 10.3389/fimmu.2017.00380.
Gam, R., Shah, P., Crossland, R. E., Norden, J., Dickinson, A. M., & Dressel, R. (2017). Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes. Frontiers in immunology, 8380. https://doi.org/10.3389/fimmu.2017.00380
Gam, Rihab, et al. "Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes." Frontiers in immunology vol. 8 (2017): 380. doi: https://doi.org/10.3389/fimmu.2017.00380
Gam R, Shah P, Crossland RE, Norden J, Dickinson AM, Dressel R. Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes. Front Immunol. 2017 Apr 03;8:380. doi: 10.3389/fimmu.2017.00380. eCollection 2017. PMID: 28421078; PMCID: PMC5377073.
Copy Download .nbib Format: NLM
Genomic-based tools for the risk assessment, management, and prevention of type 2 diabetes.

The application of clinical genetics

Johansen Taber KA, Dickinson BD.
PMID: 25609992
Appl Clin Genet. 2015 Jan 07;8:1-8. doi: 10.2147/TACG.S75583. eCollection 2015.

Type 2 diabetes (T2D) is a common and serious disorder and is a significant risk factor for the development of cardiovascular disease, neuropathy, nephropathy, retinopathy, periodontal disease, and foot ulcers and amputations. The burden of disease associated with T2D...

Cite
Johansen Taber KA, Dickinson BD. Genomic-based tools for the risk assessment, management, and prevention of type 2 diabetes. Appl Clin Genet. 2015;8:1-8doi: 10.2147/TACG.S75583.
Johansen Taber, K. A., & Dickinson, B. D. (2015). Genomic-based tools for the risk assessment, management, and prevention of type 2 diabetes. The application of clinical genetics, 81-8. https://doi.org/10.2147/TACG.S75583
Johansen Taber, Katherine A, and Dickinson, Barry D. "Genomic-based tools for the risk assessment, management, and prevention of type 2 diabetes." The application of clinical genetics vol. 8 (2015): 1-8. doi: https://doi.org/10.2147/TACG.S75583
Johansen Taber KA, Dickinson BD. Genomic-based tools for the risk assessment, management, and prevention of type 2 diabetes. Appl Clin Genet. 2015 Jan 07;8:1-8. doi: 10.2147/TACG.S75583. eCollection 2015. PMID: 25609992; PMCID: PMC4293919.
Copy Download .nbib Format: NLM
The Interplay Between Monocytes/Macrophages and CD4(+) T Cell Subsets in Rheumatoid Arthritis.

Frontiers in immunology

Roberts CA, Dickinson AK, Taams LS.
PMID: 26635790
Front Immunol. 2015 Nov 19;6:571. doi: 10.3389/fimmu.2015.00571. eCollection 2015.

Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by inflammation of the synovial lining (synovitis). The inflammation in the RA joint is associated with and driven by immune cell infiltration, synovial hyperproliferation, and excessive production of proinflammatory mediators,...

Cite
Roberts CA, Dickinson AK, Taams LS. The Interplay Between Monocytes/Macrophages and CD4(+) T Cell Subsets in Rheumatoid Arthritis. Front Immunol. 2015;6:571doi: 10.3389/fimmu.2015.00571.
Roberts, C. A., Dickinson, A. K., & Taams, L. S. (2015). The Interplay Between Monocytes/Macrophages and CD4(+) T Cell Subsets in Rheumatoid Arthritis. Frontiers in immunology, 6571. https://doi.org/10.3389/fimmu.2015.00571
Roberts, Ceri A, et al. "The Interplay Between Monocytes/Macrophages and CD4(+) T Cell Subsets in Rheumatoid Arthritis." Frontiers in immunology vol. 6 (2015): 571. doi: https://doi.org/10.3389/fimmu.2015.00571
Roberts CA, Dickinson AK, Taams LS. The Interplay Between Monocytes/Macrophages and CD4(+) T Cell Subsets in Rheumatoid Arthritis. Front Immunol. 2015 Nov 19;6:571. doi: 10.3389/fimmu.2015.00571. eCollection 2015. PMID: 26635790; PMCID: PMC4652039.
Copy Download .nbib Format: NLM
Trends in prostate cancer incidence and mortality in Canada during the era of prostate-specific antigen screening.

CMAJ open

Dickinson J, Shane A, Tonelli M, Connor Gorber S, Joffres M, Singh H, Bell N.
PMID: 27280117
CMAJ Open. 2016 Mar 02;4(1):E73-9. doi: 10.9778/cmajo.20140079. eCollection 2016.

BACKGROUND: Widespread use of prostate-specific antigen (PSA) to screen for prostate cancer began in the early 1990s. Advocates for screening assert that this has caused a decrease in prostate cancer mortality. We sought to describe secular changes in prostate...

Cite
Dickinson J, Shane A, Tonelli M, et al. Trends in prostate cancer incidence and mortality in Canada during the era of prostate-specific antigen screening. CMAJ Open. 2016;4(1):E73-9doi: 10.9778/cmajo.20140079.
Dickinson, J., Shane, A., Tonelli, M., Connor Gorber, S., Joffres, M., Singh, H., & Bell, N. (2016). Trends in prostate cancer incidence and mortality in Canada during the era of prostate-specific antigen screening. CMAJ open, 4(1), E73-9. https://doi.org/10.9778/cmajo.20140079
Dickinson, James, et al. "Trends in prostate cancer incidence and mortality in Canada during the era of prostate-specific antigen screening." CMAJ open vol. 4,1 (2016): E73-9. doi: https://doi.org/10.9778/cmajo.20140079
Dickinson J, Shane A, Tonelli M, Connor Gorber S, Joffres M, Singh H, Bell N. Trends in prostate cancer incidence and mortality in Canada during the era of prostate-specific antigen screening. CMAJ Open. 2016 Mar 02;4(1):E73-9. doi: 10.9778/cmajo.20140079. eCollection 2016. PMID: 27280117; PMCID: PMC4866930.
Copy Download .nbib Format: NLM
Corrigendum: High-throughput discovery of novel developmental phenotypes.

Nature

Dickinson ME, Flenniken AM, Ji X, Teboul L, Wong MD, White JK, Meehan TF, Weninger WJ, Westerberg H, Adissu H, Baker CN, Bower L, Brown JM, Caddle LB, Chiani F, Clary D, Cleak J, Daly MJ, Denegre JM, Doe B, Dolan ME, Edie Helmut Fuchs SM, Gailus-Durner V, Galli A, Gambadoro A, Gallegos J, Guo S, Horner NR, Hsu CW, Johnson SJ, Kalaga S, Keith LC, Lanoue L, Lawson TN, Lek M, Mark M, Marschall S, Mason J, McElwee ML, Nutter SNLMJ, Peterson KA, Ramirez-Solis R, Rowland DJ, Ryder E, Samocha KE, Seavitt JR, Selloum M, Szoke-Kovacs Z, Tamura M, Trainor AG, Tudose I, Wakana S, Warren J, Wendling O, West DB, Wong L, Yoshiki A, Wurst W, MacArthur DG, Tocchini-Valentini GP, Gao X, Flicek P, Bradley A, Skarnes WC, Justice MJ, Parkinson HE, Moore M, Wells S, Braun RE, Svenson KL, de Angelis MH, Herault Y, Mohun T, Mallon AM, Henkelman RM, Brown SDM, Adams DJ, Lloyd KCK, McKerlie C, Beaudet AL, Murray MBSA.
PMID: 29144450
Nature. 2017 Nov 16;551(7680):398. doi: 10.1038/nature24643. Epub 2017 Nov 08.

This corrects the article DOI: 10.1038/nature19356.

Cite
Dickinson ME, Flenniken AM, Ji X, et al. Corrigendum: High-throughput discovery of novel developmental phenotypes. Nature. 2017;551(7680):398doi: 10.1038/nature24643.
Dickinson, M. E., Flenniken, A. M., Ji, X., Teboul, L., Wong, M. D., White, J. K., Meehan, T. F., Weninger, W. J., Westerberg, H., Adissu, H., Baker, C. N., Bower, L., Brown, J. M., Caddle, L. B., Chiani, F., Clary, D., Cleak, J., Daly, M. J., Denegre, J. M., Doe, B., Dolan, M. E., Edie Helmut Fuchs, S. M., Gailus-Durner, V., Galli, A., Gambadoro, A., Gallegos, J., Guo, S., Horner, N. R., Hsu, C. W., Johnson, S. J., Kalaga, S., Keith, L. C., Lanoue, L., Lawson, T. N., Lek, M., Mark, M., Marschall, S., Mason, J., McElwee, M. L., Nutter, S. N. L. M. J., Peterson, K. A., Ramirez-Solis, R., Rowland, D. J., Ryder, E., Samocha, K. E., Seavitt, J. R., Selloum, M., Szoke-Kovacs, Z., Tamura, M., Trainor, A. G., Tudose, I., Wakana, S., Warren, J., Wendling, O., West, D. B., Wong, L., Yoshiki, A., Wurst, W., MacArthur, D. G., Tocchini-Valentini, G. P., Gao, X., Flicek, P., Bradley, A., Skarnes, W. C., Justice, M. J., Parkinson, H. E., Moore, M., Wells, S., Braun, R. E., Svenson, K. L., de Angelis, M. H., Herault, Y., Mohun, T., Mallon, A. M., Henkelman, R. M., Brown, S. D. M., Adams, D. J., Lloyd, K. C. K., McKerlie, C., Beaudet, A. L., & Murray, M. B. S. A. (2017). Corrigendum: High-throughput discovery of novel developmental phenotypes. Nature, 551(7680), 398. https://doi.org/10.1038/nature24643
Dickinson, Mary E, et al. "Corrigendum: High-throughput discovery of novel developmental phenotypes." Nature vol. 551,7680 (2017): 398. doi: https://doi.org/10.1038/nature24643
Dickinson ME, Flenniken AM, Ji X, Teboul L, Wong MD, White JK, Meehan TF, Weninger WJ, Westerberg H, Adissu H, Baker CN, Bower L, Brown JM, Caddle LB, Chiani F, Clary D, Cleak J, Daly MJ, Denegre JM, Doe B, Dolan ME, Edie Helmut Fuchs SM, Gailus-Durner V, Galli A, Gambadoro A, Gallegos J, Guo S, Horner NR, Hsu CW, Johnson SJ, Kalaga S, Keith LC, Lanoue L, Lawson TN, Lek M, Mark M, Marschall S, Mason J, McElwee ML, Nutter SNLMJ, Peterson KA, Ramirez-Solis R, Rowland DJ, Ryder E, Samocha KE, Seavitt JR, Selloum M, Szoke-Kovacs Z, Tamura M, Trainor AG, Tudose I, Wakana S, Warren J, Wendling O, West DB, Wong L, Yoshiki A, Wurst W, MacArthur DG, Tocchini-Valentini GP, Gao X, Flicek P, Bradley A, Skarnes WC, Justice MJ, Parkinson HE, Moore M, Wells S, Braun RE, Svenson KL, de Angelis MH, Herault Y, Mohun T, Mallon AM, Henkelman RM, Brown SDM, Adams DJ, Lloyd KCK, McKerlie C, Beaudet AL, Murray MBSA. Corrigendum: High-throughput discovery of novel developmental phenotypes. Nature. 2017 Nov 16;551(7680):398. doi: 10.1038/nature24643. Epub 2017 Nov 08. PMID: 29144450; PMCID: PMC5849394.
Copy Download .nbib Format: NLM
Clinical outcomes associated with serial sharp debridement of diabetic foot ulcers with and without clostridial collagenase ointment.

Wounds : a compendium of clinical research and practice

Motley TA, Lange DL, Dickerson JE, Slade HB.
PMID: 25860329
Wounds. 2014 Mar;26(3):57-64.

OBJECTIVE: Fifty-five subjects with diabetes mellitus type 1 or 2 and a neuropathic, nonischemic foot ulcer were enrolled into this randomized, controlled, multicenter trial designed to examine the effects of debridement with clostridial collagenase ointment (CCO) used in conjunction...

Cite
Motley TA, Lange DL, Dickerson JE, et al. Clinical outcomes associated with serial sharp debridement of diabetic foot ulcers with and without clostridial collagenase ointment. Wounds. 2014;26(3):57-64
Motley, T. A., Lange, D. L., Dickerson, J. E., & Slade, H. B. (2014). Clinical outcomes associated with serial sharp debridement of diabetic foot ulcers with and without clostridial collagenase ointment. Wounds : a compendium of clinical research and practice, 26(3), 57-64.
Motley, Travis A, et al. "Clinical outcomes associated with serial sharp debridement of diabetic foot ulcers with and without clostridial collagenase ointment." Wounds : a compendium of clinical research and practice vol. 26,3 (2014): 57-64.
Motley TA, Lange DL, Dickerson JE, Slade HB. Clinical outcomes associated with serial sharp debridement of diabetic foot ulcers with and without clostridial collagenase ointment. Wounds. 2014 Mar;26(3):57-64. PMID: 25860329.
Copy Download .nbib Format: NLM
[Les zèbres mélaniques: Leurs soins et alimentation].

Canadian family physician Medecin de famille canadien

Dickinson JA.
PMID: 27521402
Can Fam Physician. 2016 Aug;62(8):e422-3.

No abstract available.

Cite
Dickinson JA. [Les zèbres mélaniques: Leurs soins et alimentation]. Can Fam Physician. 2016;62(8):e422-3
Dickinson, J. A. (2016). [Les zèbres mélaniques: Leurs soins et alimentation]. Canadian family physician Medecin de famille canadien, 62(8), e422-3.
Dickinson, James A. "[Les zèbres mélaniques: Leurs soins et alimentation]." Canadian family physician Medecin de famille canadien vol. 62,8 (2016): e422-3.
Dickinson JA. [Les zèbres mélaniques: Leurs soins et alimentation]. Can Fam Physician. 2016 Aug;62(8):e422-3. French. PMID: 27521402; PMCID: PMC4982735.
Copy Download .nbib Format: NLM
The Management of Diabetic Foot Ulcers with Porcine Small Intestine Submucosa Tri-Layer Matrix: A Randomized Controlled Trial.

Advances in wound care

Cazzell SM, Lange DL, Dickerson JE, Slade HB.
PMID: 26634183
Adv Wound Care (New Rochelle). 2015 Dec 01;4(12):711-718. doi: 10.1089/wound.2015.0645.

No abstract available.

Cite
Cazzell SM, Lange DL, Dickerson JE, et al. The Management of Diabetic Foot Ulcers with Porcine Small Intestine Submucosa Tri-Layer Matrix: A Randomized Controlled Trial. Adv Wound Care (New Rochelle). 2015;4(12):711-718doi: 10.1089/wound.2015.0645.
Cazzell, S. M., Lange, D. L., Dickerson, J. E., & Slade, H. B. (2015). The Management of Diabetic Foot Ulcers with Porcine Small Intestine Submucosa Tri-Layer Matrix: A Randomized Controlled Trial. Advances in wound care, 4(12), 711-718. https://doi.org/10.1089/wound.2015.0645
Cazzell, Shawn M, et al. "The Management of Diabetic Foot Ulcers with Porcine Small Intestine Submucosa Tri-Layer Matrix: A Randomized Controlled Trial." Advances in wound care vol. 4,12 (2015): 711-718. doi: https://doi.org/10.1089/wound.2015.0645
Cazzell SM, Lange DL, Dickerson JE, Slade HB. The Management of Diabetic Foot Ulcers with Porcine Small Intestine Submucosa Tri-Layer Matrix: A Randomized Controlled Trial. Adv Wound Care (New Rochelle). 2015 Dec 01;4(12):711-718. doi: 10.1089/wound.2015.0645. PMID: 26634183; PMCID: PMC4651054.
Copy Download .nbib Format: NLM
Dangers for surgeons.

BMJ (Clinical research ed.)

Dickinson E.
PMID: 10582936
BMJ. 1999 Dec 04;319(7223):1480A. doi: 10.1136/bmj.319.7223.1480a.

No abstract available.

Cite
Dickinson E. Dangers for surgeons. BMJ. 1999;319(7223):1480Adoi: 10.1136/bmj.319.7223.1480a.
Dickinson, E. (1999). Dangers for surgeons. BMJ (Clinical research ed.), 319(7223), 1480A. https://doi.org/10.1136/bmj.319.7223.1480a
Dickinson. "Dangers for surgeons." BMJ (Clinical research ed.) vol. 319,7223 (1999): 1480A. doi: https://doi.org/10.1136/bmj.319.7223.1480a
Dickinson E. Dangers for surgeons. BMJ. 1999 Dec 04;319(7223):1480A. doi: 10.1136/bmj.319.7223.1480a. PMID: 10582936; PMCID: PMC1117207.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 388 entries